The NIH Office of Technology Transfer (OTT) evaluates, protects, monitors, and manages the NIH and FDA intramural research invention portfolios. These portfolios cover the broad spectrum of public health concerns including heart disease, cancer, infectious diseases, neurological disorders, respiratory illnesses, mental well-being, musculoskeletal disorders, drug/alcohol addiction, aging, and many others. Technologies include those with potential application as diagnostics, therapeutics, and vaccines; research materials are also available.
Activity:
Product / Technology type(s) covered:
- Diagnostics
- Pharmaceuticals / Therapeutics
Therapeutic targets:
|
Company Contact
|
National Institute of Health (NIH)
United States of America
Phone:
FAX:
Website: www.nih.gov/od/ott/
|
|